| Natural Antidiabetic Agents Studies | Lifetime | 18 | IR 3 | 99.66 |
| Diabetic Foot Ulcer Assessment and Management | Lifetime | 74 | IR 1 | 98.92 |
| Health and Well-being Studies | Lifetime | 74 | IR 32 | 98.26 |
| Diet and metabolism studies | Lifetime | 473 | IR 5 | 99.11 |
| Wound Healing and Treatments | Lifetime | 157 | IR 1 | 98.72 |
| Bone health and osteoporosis research | Lifetime | 164 | IR 1 | 99.12 |
| Nutrition and Health in Aging | Lifetime | 289 | IR 1 | 98.80 |
| Diabetes Management and Education | Lifetime | 99 | IR 2 | 98.70 |
| Ethics in medical practice | Lifetime | 82 | IR 1 | 98.43 |
| Chronic Disease Management Strategies | Lifetime | 181 | IR 1 | 98.52 |
| Vitamin D Research Studies | Lifetime | 169 | IR 1 | 98.55 |
| Diet, Metabolism, and Disease | Lifetime | 339 | IR 6 | 98.24 |
| Nutritional Studies and Diet | Lifetime | 477 | IR 7 | 98.37 |
| Bone Metabolism and Diseases | Lifetime | 247 | IR 1 | 98.25 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 470 | IR 8 | 98.43 |
| Heterocyclic Compound Synthesis and Bioactivity | Lifetime | 696 | IR 69 | 96.84 |
| Nutrition, Genetics, and Disease | Lifetime | 255 | IR 3 | 96.79 |
| Mesenchymal stem cell research | Lifetime | 589 | IR 8 | 97.32 |
| Bone health and treatments | Lifetime | 564 | IR 2 | 97.47 |
| Global Public Health Policies and Epidemiology | Lifetime | 283 | IR 3 | 96.74 |
| Hip and Femur Fractures | Lifetime | 442 | IR 1 | 97.59 |
| Diabetes and associated disorders | Lifetime | 809 | IR 2 | 97.24 |
| Thyroid Cancer Diagnosis and Treatment | Lifetime | 466 | IR 3 | 97.48 |
| Organ Donation and Transplantation | Lifetime | 397 | IR 1 | 97.12 |
| Diabetes Management and Research | Lifetime | 914 | IR 3 | 97.19 |
| Dietary Effects on Health | Lifetime | 189 | IR 3 | 96.18 |
| Healthcare Systems and Reforms | Lifetime | 328 | IR 13 | 96.22 |
| Ethics and Legal Issues in Pediatric Healthcare | Lifetime | 281 | IR 1 | 94.23 |
| Pharmacology and Obesity Treatment | Lifetime | 457 | IR 2 | 95.26 |
| Vitamin C and Antioxidants Research | Lifetime | 523 | IR 5 | 93.89 |
| Pressure Ulcer Prevention and Management | Lifetime | 289 | IR 1 | 94.46 |
| Advanced Glycation End Products research | Lifetime | 664 | IR 6 | 92.97 |
| Medical Malpractice and Liability Issues | Lifetime | 799 | IR 7 | 91.10 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 902 | IR 3 | 87.53 |
| Patient Dignity and Privacy | Lifetime | 722 | IR 13 | 89.52 |
| Nuts composition and effects | Lifetime | 711 | IR 40 | 87.13 |
| Ophthalmology and Visual Health Research | Lifetime | 378 | IR 61 | 85.79 |
| Biomedical Ethics and Regulation | Lifetime | 904 | IR 1 | 85.08 |
| Organ and Tissue Transplantation Research | Lifetime | 903 | IR 1 | 86.38 |
| Biomarkers in Disease Mechanisms | Lifetime | 759 | IR 3 | 81.94 |
| Natural Compound Pharmacology Studies | Lifetime | 834 | IR 5 | 76.50 |
| History of Medicine Studies | Lifetime | 697 | IR 39 | 73.93 |
| Silymarin and Mushroom Poisoning | Lifetime | 734 | IR 55 | 63.38 |
| Historical and modern epidemiology studies | Lifetime | 232 | IR 21 | 26.57 |
| Diet and metabolism studies | 2021-2025 | 195 | IR 7 | 97.67 |
| Bone health and osteoporosis research | 2021-2025 | 79 | IR 2 | 96.20 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 107 | IR 4 | 93.53 |
| Chronic Disease Management Strategies | 2021-2025 | 160 | IR 1 | 94.78 |
| Long-Term Effects of COVID-19 | 2021-2025 | 745 | IR 12 | 94.23 |
| Nutrition and Health in Aging | 2021-2025 | 395 | IR 2 | 95.59 |
| Chemical Synthesis and Analysis | 2021-2025 | 137 | IR 4 | 94.46 |
| Click Chemistry and Applications | 2021-2025 | 144 | IR 5 | 94.08 |
| Nutritional Studies and Diet | 2021-2025 | 394 | IR 24 | 95.35 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 199 | IR 10 | 92.45 |
| Diet, Metabolism, and Disease | 2021-2025 | 269 | IR 14 | 92.71 |
| Health and Well-being Studies | 2021-2025 | 113 | IR 53 | 90.50 |
| Hip and Femur Fractures | 2021-2025 | 332 | IR 2 | 92.29 |
| Pluripotent Stem Cells Research | 2021-2025 | 225 | IR 1 | 89.95 |
| Global Health Care Issues | 2021-2025 | 333 | IR 4 | 87.99 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 574 | IR 3 | 89.99 |
| Healthcare Systems and Reforms | 2021-2025 | 259 | IR 18 | 90.27 |
| Global Cancer Incidence and Screening | 2021-2025 | 650 | IR 15 | 90.99 |
| Vitamin D Research Studies | 2021-2025 | 260 | IR 13 | 87.70 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 522 | IR 24 | 89.89 |
| Mesenchymal stem cell research | 2021-2025 | 470 | IR 32 | 87.94 |
| Diabetes Management and Education | 2021-2025 | 310 | IR 4 | 87.31 |
| Frailty in Older Adults | 2021-2025 | 909 | IR 4 | 88.18 |
| Synthesis of heterocyclic compounds | 2021-2025 | 42 | IR 2 | 85.16 |
| Phenothiazines and Benzothiazines Synthesis and Activities | 2021-2025 | 129 | IR 2 | 83.54 |
| Synthesis and Catalytic Reactions | 2021-2025 | 386 | IR 3 | 85.96 |
| Quinazolinone synthesis and applications | 2021-2025 | 168 | IR 19 | 81.93 |
| Synthesis and Characterization of Heterocyclic Compounds | 2021-2025 | 450 | IR 31 | 85.55 |
| Synthesis and Biological Evaluation | 2021-2025 | 498 | IR 21 | 83.27 |
| Carbohydrate Chemistry and Synthesis | 2021-2025 | 374 | IR 7 | 82.75 |
| Dietary Effects on Health | 2021-2025 | 348 | IR 9 | 81.22 |
| melanin and skin pigmentation | 2021-2025 | 385 | IR 13 | 80.82 |
| Body Composition Measurement Techniques | 2021-2025 | 488 | IR 4 | 82.08 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 462 | IR 10 | 77.46 |
| Ethics in medical practice | 2021-2025 | 290 | IR 18 | 79.64 |
| Metabolism and Genetic Disorders | 2021-2025 | 932 | IR 6 | 78.83 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 971 | IR 13 | 77.68 |
| Catalytic Cross-Coupling Reactions | 2021-2025 | 801 | IR 26 | 78.52 |
| Biochemical and Molecular Research | 2021-2025 | 477 | IR 4 | 72.97 |
| Health Sciences Research and Education | 2021-2025 | 280 | IR 2 | 73.38 |
| Vitamin C and Antioxidants Research | 2021-2025 | 353 | IR 15 | 72.71 |
| Chemical synthesis and alkaloids | 2021-2025 | 431 | IR 4 | 73.90 |
| Enzyme function and inhibition | 2021-2025 | 192 | IR 2 | 76.11 |
| Nutrition, Genetics, and Disease | 2021-2025 | 698 | IR 26 | 72.36 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 257 | IR 13 | 70.72 |
| Multicomponent Synthesis of Heterocycles | 2021-2025 | 672 | IR 213 | 74.76 |
| Obesity and Health Practices | 2021-2025 | 806 | IR 13 | 72.14 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 941 | IR 23 | 72.02 |
| Nuts composition and effects | 2021-2025 | 406 | IR 22 | 68.57 |
| Psidium guajava Extracts and Applications | 2021-2025 | 154 | IR 6 | 62.43 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 421 | IR 11 | 59.57 |
| Pressure Ulcer Prevention and Management | 2021-2025 | 880 | IR 18 | 58.59 |
| Zebrafish Biomedical Research Applications | 2021-2025 | 971 | IR 3 | 56.59 |
| Catalytic Alkyne Reactions | 2021-2025 | 933 | IR 6 | 51.94 |
| Synthesis and pharmacology of benzodiazepine derivatives | 2021-2025 | 59 | IR 1 | 49.34 |
| Ophthalmology and Visual Health Research | 2021-2025 | 508 | IR 25 | 43.89 |
| Synthesis of Organic Compounds | 2021-2025 | 852 | IR 61 | 38.15 |
| Synthesis and Characterization of Pyrroles | 2021-2025 | 353 | IR 10 | 30.18 |